Your Space - Health and Fitness

Familial hypercholesterolemia is a serious condition that causes very high cholesterol levels. This inherited disorder greatly increases your chances of having a heart attack early in life.

What factors contribute to

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

hypercholesterolemia disease?

We all know that cholesterol plays a role in cardiovascular health. Under normal circumstances it is removed from the blood via low-density lipoprotein (LDL) receptors. Two genes (one

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

inherited from the father, one from the mother) are responsible for making LDL receptors.

If you have familial hypercholesterolemia or FH, an abnormal gene has been passed on to you from a parent with FH. Because of

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

this, half of the LDL receptors are missing or do not work the way they should to remove cholesterol normally, and levels increase in the blood.

People with FH have consistently high levels of low-density lipoprotein

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

which leads to premature atherosclerosis of the coronary arteries.

If you have hypercholesterolemia disease, this will result in damage to blood vessels, blockage of arteries, and heart attacks that occur at an earl

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ier age.

Your children will also face a 50% chance of inheriting this disorder. It is recommended that children in a FH family be checked at age two. It is possible for someone to inherit two genes for this disorder!

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

If you have familial hypercholesterolemia, what can you do? Early diagnosis is crucial to prevent early death.

The goal in treating hypercholesterolemia disease is to reduce the risk of atherosclerotic heart diseas

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

e and heart attack.

Changing what you eat may help. This would include reducing total fat intake to less than 30% from calories consumed. Saturated fat intake can be reduced by decreasing the amount of pork, lamb, or

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

beef you eat, by switching to low-fat dairy products, by eliminating certain oils, such as coconut and palm oil, and by curbing consumption of egg yolks and organ meats.

In treating familial hypercholesterolemia, fur

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ther reductions in fat may be necessary. Dietary counseling is a must to aid in necessary adjustments to eating habits.

Exercise is also important when trying to combat hypercholesterolemia disease. The goal should b

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

e to reduce weight to aid in lowering cholesterol levels.

After a trial period, drug therapy may be initiated if diet, exercise, and weight-loss efforts have not reduced cholesterol levels for people with familial hy

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

percholesterolemia. Cholesterol-reducing agents are available: lovastatin and other statin drugs, gemfibrozil, probucol, or bile acid sequestrant resins.

Outcomes vary, depending upon the type of hypercholesterolemia

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

disease you have. For example, if you have the homozygote type, it can cause early heart attacks and is resistant to treatment.

The outcome for other types depends, in part, on your compliance with treatment. Fortuna

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

tely, serum cholesterol levels can be reduced.

Natural substances can also render significant protective effects in relation to heart health and cardiovascular functioning.

One substance, beta-sitosterol, is used fo

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

r coronary heart disease and hypercholesterolemia. This plant sterol has a chemical structure similar to cholesterol and it inhibits intestinal absorption of cholesterol. In fact, cholesterol absorption is decreased b

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

y about 50%. A concentrated form of vitamin E (tocotrienol rich fraction or TRF) is isolated from rice bran oil. Its properties inhibit the activity of an enzyme involved in cholesterol biosynthesis. A case study of a

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

five-year-old boy in India, who had familial hypercholesterolemia (with total cholesterol that had climbed to 440mg/dL) r

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

evealed that he experienced a 20% decline after about two months of tocotrienol supplements. Lecithin oil is another substance that renders an inhibitory effect on absorption of cholesterol. It is also beneficial for

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

those suffering from vascular disorders and from heart disease.

Natural substances contain scientifically formulated ingredients that can protect heart health, while bringing LDL and HDL into desired ranges. Hypercho

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

lesterolemia disease is a serious condition that should be treated.

If you suffer from familial hypercholesterolemia, it is extremely important to obtain medical advice and to implement strategies to reduce your risk

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.yourspace.org.ua/article/250337/yourspace-Familial-Hypercholesterolemia-A-Serious-Inherited-Condition.html">Familial Hypercholesterolemia: A Serious Inherited Condition</a>

BB link (for phorums):
[url=http://www.yourspace.org.ua/article/250337/yourspace-Familial-Hypercholesterolemia-A-Serious-Inherited-Condition.html]Familial Hypercholesterolemia: A Serious Inherited Condition[/url]

This article discusses whether or not airline miles credit cards are necessary for consumers.

This is the fourth article in a series that examines common products, how their manufacture and consumption affects the environment and how we can use less in our day-to-day lives. This article discusses the use of gasoline.

Confusion is the result of a sudden mental malfunction associated with the inability to focus attention. It is a general symptom of brain dysfunction caused by many factors such as neurological, metabolic and even circulatory. The most common of the factors are the neurological disorders. One neurological disorder that can have effects to the circulatory system is the idiopathic intracranial hypertension.

Tags

Links

Your Space - Familial Hypercholesterolemia: A Serious Inherited Condition

Related Articles: